Literature DB >> 8578452

The enigma PAI-2. Gene expression, evolutionary and functional aspects.

F Bachmann1.   

Abstract

The type-2 plasminogen activator inhibitor (PAI-2) belongs to the ovalbumin subfamily of serpins. It exhibits close to 50% homology with several recently cloned protease inhibitors such as the leukocyte elastase inhibitor, the placental thrombin inhibitor and the squamous cell carcinoma antigen. PAI-2 exists in an intracellular, nonglycosylated form of 47 kDa and a secreted, glycosylated form of about 60 kDa. The PAI-2 gene does not have a signal peptide which might explain why the major portion of PAI-2 remains intracellularly. Several response elements have been identified in the promoter region which are necessary for constitutive and phorbol ester and retinoic acid induced expression of the gene. These include two AP-1 sites, and response elements for cAMP, glucocorticoids and retinoic acid. The physiological function of PAI-2 has not been clearly elucidated. It may have cytoprotective functions and appears to play a role in programmed cell death.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8578452

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  4 in total

1.  A redox-sensitive loop regulates plasminogen activator inhibitor type 2 (PAI-2) polymerization.

Authors:  Malgorzata Wilczynska; Sergei Lobov; Per-Ingvar Ohlsson; Tor Ny
Journal:  EMBO J       Date:  2003-04-15       Impact factor: 11.598

2.  Abnormal expression of plasminogen activator inhibitors in patients with gestational trophoblastic disease.

Authors:  A Estellés; S Grancha; J Gilabert; T Thinnes; M Chirivella; F España; J Aznar; D J Loskutoff
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

3.  Inhibition of B16BL6 melanoma invasion by tyrosine and phenylalanine deprivation is associated with decreased secretion of plasminogen activators and increased plasminogen activator inhibitors.

Authors:  B A Pelayo; Y M Fu; G G Meadows
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

4.  A mesangium-predominant gene, megsin, is a new serpin upregulated in IgA nephropathy.

Authors:  T Miyata; M Nangaku; D Suzuki; R Inagi; K Uragami; H Sakai; K Okubo; K Kurokawa
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.